Related Experiment Video
Updated: May 14, 2026

06:51
Real-Time Monitoring of Human Glioma Cell Migration on Dorsal Root Ganglion Axon-Oligodendrocyte Co-Cultures
Published on: December 13, 2019
Testosterone-TGF-β crosstalk modulates cell migration in human glioblastoma-derived cell lines
Omar Rafael Alemán1, Juan Carlos Quintero1, Laura Noemi Hernández-Lúa1
1Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 11000, Mexico.
Steroids
|May 12, 2026
Summary
Testosterone (T) influences glioblastoma (GB) cell migration by modulating transforming growth factor-β (TGF-β) signaling. This effect is cell-line specific, impacting U251 cells but not T98G cells.
Area of Science:
- Neuroscience
- Oncology
- Endocrinology
Background:
- Glioblastoma (GB) is an aggressive brain tumor characterized by significant cellular migration.
- Testosterone (T) and transforming growth factor-β (TGF-β) are known regulators of GB cell migration, but their interaction is not fully understood.
Purpose of the Study:
- To investigate whether testosterone modulates TGF-β signaling pathways to influence cell migration in human glioblastoma-derived cell lines.
- To identify potential androgen response elements (AREs) in the TGF-β gene.
Main Methods:
- In-silico identification of AREs within the TGF-β gene.
- Evaluation of T's effects on TGF-β secretion (ELISA) and SMAD signaling activation (Western blot) in U251 and T98G cells.
- Assessment of cell migration using scratch assays with and without the TGF-β pathway inhibitor SB431542.
Main Results:
- Seven AREs were identified in the TGF-β gene.
- Testosterone significantly increased TGF-β secretion and SMAD activation in U251 cells, but not in T98G cells.
- Inhibition of TGF-β signaling abrogated testosterone-stimulated migration solely in U251 cells.
Conclusions:
- Testosterone activates TGF-β signaling to promote glioblastoma cell migration in a cell-line specific manner (U251 cells).
- This study reveals heterogeneity in glioblastoma cell response to hormonal stimuli, impacting therapeutic strategies.

